Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotic-Lock for Relapsing and Repeat Peritonitis in PD
NCT05971537Phase 4Recruiting
- Sponsor
- Alice Ho Miu Ling Nethersole Hospital
- Start
- Jun 2023
- Primary completion
- Oct 2026
- Modality
- Reversible Covalent Inhibitors, Nanoparticles, Cyclic Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of cefazolin, ceftazidime, vancomycin, gentamicin, imipenem in peritonitis, sponsored by Alice Ho Miu Ling Nethersole Hospital. Started Jun 2023; status: recruiting.
02
Drugs
cefazolinceftazidimevancomycingentamicinimipenem
03
Conditions
peritonitis
Beyond the preview
Go deeper on NCT05971537.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05971537.